About Innosieve Diagnostics
Innosieve Diagnostics is a Healthcare company based in Wageningen (Netherlands) founded in 2007. Microbial diagnostic test kits are provided for contamination analysis. Innosieve Diagnostics has completed 1 acquisition, including LumiByte. Innosieve Diagnostics offers products and services including MuScan Device, MuScan Software, and Sieve-ID Kits. Its focus areas include Diversified Diagnostics, Life Sciences, Genomics and Enabling Technologies. Its legal entity is Innosieve Diagnostics BV.
Company details
Innosieve Diagnostics was founded in 2007 in Wageningen, Netherlands. Microbial diagnostic test kits are supplied within the biotechnology sector. The Sieve-ID platform is utilized for contamination detection, employing solid-phase cytometry. Microbes are captured on a membrane, subjected to washing and staining, then scanned via the automated MuScan device. Operations focus on laboratory-based analysis services across Europe.
- Headquarters Wageningen, Netherlands
- SectorsHealthcare
- Email••••••••
- Website innosieve.com
- Social LinkedIn X Facebook
- Legal Name Innosieve Diagnostics Bv
- Latest Funding Round$66.13K (USD), Grant
Apr 2021
- Investors
- Investments & Acquisitions
Products & Services of Innosieve Diagnostics
Innosieve Diagnostics offers a comprehensive portfolio of products and services, including MuScan Device, MuScan Software, and Sieve-ID Kits.
LED-based optical device for rapid microbial scanning and analysis.
GMP compliant tool for microbial quantification and data management.
Validated kits for direct microbial detection in samples.
Funding Insights of Innosieve Diagnostics
- Total Rounds 2
- Last Round Grant — $66,129
- First Round $702,710
(Jan 2021)
- Investors Count 1
All 2 funding rounds of Innosieve Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2021 | $66,129 | Grant | – | – | |
| Jan 2021 | $702,710 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Innosieve Diagnostics
Innosieve Diagnostics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Innosieve Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Innosieve Diagnostics
Innosieve Diagnostics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include LumiByte.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Microbial detection and real-time growth monitoring systems are provided. | lumibyte.eu | Nuenen, Netherlands | 2010 | Jul 2017 | •••• |
Complete acquisition details for Innosieve Diagnostics
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Innosieve Diagnostics
4 dated milestones of Innosieve Diagnostics across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Innosieve Diagnostics is founded.
- Acquisition Acquires LumiByte.
- Funding First funding round of $703K.
- Funding Latest funding round, Grant, of $66K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Innosieve Diagnostics
Complete news archive for Innosieve Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Innosieve Diagnostics
Innosieve Diagnostics was founded in 2007 and raised its 1st funding round 14 years after it was founded.
Innosieve Diagnostics is headquartered in Wageningen, Netherlands. It is registered at Wageningen, Gelderland, Netherlands.
Innosieve Diagnostics was founded in 2007 in Wageningen, Netherlands. Microbial diagnostic test kits are supplied within the biotechnology sector. The Sieve-ID platform is utilized for contamination detection, employing solid-phase cytometry. Microbes are captured on a membrane, subjected to washing and staining, then scanned via the automated MuScan device. Operations focus on laboratory-based analysis services across Europe.
Innosieve Diagnostics offers MuScan Device, MuScan Software, and Sieve-ID Kits.
Innosieve Diagnostics has made 1 acquisition, including LumiByte.
Innosieve Diagnostics has 1 investor. Key investors include European Union.
Innosieve Diagnostics operates through Innosieve Diagnostics Bv.